Prime Medicine (PRME) Accumulated Depreciation & Amortization (2021 - 2025)
Historic Accumulated Depreciation & Amortization for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $1.9 million.
- Prime Medicine's Accumulated Depreciation & Amortization rose 2073.17% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 2073.17%. This contributed to the annual value of $6.1 million for FY2024, which is 3170.0% up from last year.
- According to the latest figures from Q3 2025, Prime Medicine's Accumulated Depreciation & Amortization is $1.9 million, which was up 2073.17% from $1.9 million recorded in Q2 2025.
- Prime Medicine's Accumulated Depreciation & Amortization's 5-year high stood at $6.1 million during Q4 2024, with a 5-year trough of $200000.0 in Q3 2021.
- In the last 5 years, Prime Medicine's Accumulated Depreciation & Amortization had a median value of $1.3 million in 2024 and averaged $1.7 million.
- Per our database at Business Quant, Prime Medicine's Accumulated Depreciation & Amortization surged by 27066.67% in 2022 and then skyrocketed by 2073.17% in 2025.
- Over the past 5 years, Prime Medicine's Accumulated Depreciation & Amortization (Quarter) stood at $600000.0 in 2021, then skyrocketed by 270.67% to $2.2 million in 2022, then surged by 109.22% to $4.7 million in 2023, then surged by 31.7% to $6.1 million in 2024, then plummeted by 69.3% to $1.9 million in 2025.
- Its Accumulated Depreciation & Amortization was $1.9 million in Q3 2025, compared to $1.9 million in Q2 2025 and $1.7 million in Q1 2025.